Statins and Peripheral Arterial Disease: A Narrative Review
Peripheral arterial disease (PAD) is a highly prevalent atherosclerotic condition. In patients with PAD, the presence of intermittent claudication leads to a deterioration in quality of life. In addition, even in asymptomatic cases, patients with PAD are at high risk of cardiac or cerebrovascular ev...
Guardado en:
Autores principales: | , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/eedbdd44b7164bd286186756619f2d22 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:eedbdd44b7164bd286186756619f2d22 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:eedbdd44b7164bd286186756619f2d222021-11-22T06:05:30ZStatins and Peripheral Arterial Disease: A Narrative Review2297-055X10.3389/fcvm.2021.777016https://doaj.org/article/eedbdd44b7164bd286186756619f2d222021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fcvm.2021.777016/fullhttps://doaj.org/toc/2297-055XPeripheral arterial disease (PAD) is a highly prevalent atherosclerotic condition. In patients with PAD, the presence of intermittent claudication leads to a deterioration in quality of life. In addition, even in asymptomatic cases, patients with PAD are at high risk of cardiac or cerebrovascular events. Treatment of PAD is based on lifestyle modifications; regular exercise; smoking cessation; and control of cardiovascular risk factors, including hypercholesterolemia. A growing number of studies have shown that statins reduce cardiovascular risk and improve symptoms associated with PAD. Current guidelines recommend the use of statins in all patients with PAD in order to decrease cardiovascular events and mortality. However, the prescribing of statins in patients with PAD is lower than in those with coronary heart disease. This review provides relevant information from the literature that supports the use of statins in patients with PAD and shows their potential benefit in decreasing lower limb complications as well as cardiovascular morbidity and mortality.Sergio Jansen-ChaparroMaría D. López-CarmonaLidia Cobos-PalaciosJaime Sanz-CánovasM. Rosa Bernal-LópezM. Rosa Bernal-LópezRicardo Gómez-HuelgasRicardo Gómez-HuelgasFrontiers Media S.A.articlestatinsperipheral arterial diseasecardiovascular riskamputationcritical limb ischemiaDiseases of the circulatory (Cardiovascular) systemRC666-701ENFrontiers in Cardiovascular Medicine, Vol 8 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
statins peripheral arterial disease cardiovascular risk amputation critical limb ischemia Diseases of the circulatory (Cardiovascular) system RC666-701 |
spellingShingle |
statins peripheral arterial disease cardiovascular risk amputation critical limb ischemia Diseases of the circulatory (Cardiovascular) system RC666-701 Sergio Jansen-Chaparro María D. López-Carmona Lidia Cobos-Palacios Jaime Sanz-Cánovas M. Rosa Bernal-López M. Rosa Bernal-López Ricardo Gómez-Huelgas Ricardo Gómez-Huelgas Statins and Peripheral Arterial Disease: A Narrative Review |
description |
Peripheral arterial disease (PAD) is a highly prevalent atherosclerotic condition. In patients with PAD, the presence of intermittent claudication leads to a deterioration in quality of life. In addition, even in asymptomatic cases, patients with PAD are at high risk of cardiac or cerebrovascular events. Treatment of PAD is based on lifestyle modifications; regular exercise; smoking cessation; and control of cardiovascular risk factors, including hypercholesterolemia. A growing number of studies have shown that statins reduce cardiovascular risk and improve symptoms associated with PAD. Current guidelines recommend the use of statins in all patients with PAD in order to decrease cardiovascular events and mortality. However, the prescribing of statins in patients with PAD is lower than in those with coronary heart disease. This review provides relevant information from the literature that supports the use of statins in patients with PAD and shows their potential benefit in decreasing lower limb complications as well as cardiovascular morbidity and mortality. |
format |
article |
author |
Sergio Jansen-Chaparro María D. López-Carmona Lidia Cobos-Palacios Jaime Sanz-Cánovas M. Rosa Bernal-López M. Rosa Bernal-López Ricardo Gómez-Huelgas Ricardo Gómez-Huelgas |
author_facet |
Sergio Jansen-Chaparro María D. López-Carmona Lidia Cobos-Palacios Jaime Sanz-Cánovas M. Rosa Bernal-López M. Rosa Bernal-López Ricardo Gómez-Huelgas Ricardo Gómez-Huelgas |
author_sort |
Sergio Jansen-Chaparro |
title |
Statins and Peripheral Arterial Disease: A Narrative Review |
title_short |
Statins and Peripheral Arterial Disease: A Narrative Review |
title_full |
Statins and Peripheral Arterial Disease: A Narrative Review |
title_fullStr |
Statins and Peripheral Arterial Disease: A Narrative Review |
title_full_unstemmed |
Statins and Peripheral Arterial Disease: A Narrative Review |
title_sort |
statins and peripheral arterial disease: a narrative review |
publisher |
Frontiers Media S.A. |
publishDate |
2021 |
url |
https://doaj.org/article/eedbdd44b7164bd286186756619f2d22 |
work_keys_str_mv |
AT sergiojansenchaparro statinsandperipheralarterialdiseaseanarrativereview AT mariadlopezcarmona statinsandperipheralarterialdiseaseanarrativereview AT lidiacobospalacios statinsandperipheralarterialdiseaseanarrativereview AT jaimesanzcanovas statinsandperipheralarterialdiseaseanarrativereview AT mrosabernallopez statinsandperipheralarterialdiseaseanarrativereview AT mrosabernallopez statinsandperipheralarterialdiseaseanarrativereview AT ricardogomezhuelgas statinsandperipheralarterialdiseaseanarrativereview AT ricardogomezhuelgas statinsandperipheralarterialdiseaseanarrativereview |
_version_ |
1718418136835817472 |